AIFM2 and non-small cell lung carcinoma: In lung cancer, for example, Song et al. reported that exosome miR-4443 regulates the expression of FSP1 via METLL3 through m6A modification, increasing cisplatin resistance and reducing the efficacy of non-small cell lung cancer (NSCLC) treatments (Song et al., 2021).